Who owns ALX ONCOLOGY HLDGS INC COM?

Tip: Access positions for across all investors

Analyze quarterly positions in Alx Oncology Hldgs with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Alx Oncology Hldgs stock

Who bought or sold ALX ONCOLOGY HLDGS INC COM this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
venBio Partners 9.7M $11M 0% Dec 2025
 View chart
Millennium Management 3.3M $3.7M 24% Dec 2025
 View chart
Redmile Group 3.3M $3.7M -2% Dec 2025
 View chart
Almitas Capital 2.5M $2.9M 0% Dec 2025
 View chart
Vanguard Group 1.6M $1.8M 7% Dec 2025
 View chart
Driehaus Capital Management 1.4M $1.6M 79% Dec 2025
 View chart
Acadian Asset Management 1.4M $1.6M 13% Dec 2025
 View chart
UBS Group 866k $979k 402% Dec 2025
 View chart
Two Sigma Advisers 710k $803k -1% Dec 2025
 View chart
Two Sigma Investments 640k $723k 6% Dec 2025
 View chart
BlackRock 450k $509k 1% Dec 2025
 View chart
Renaissance Technologies 423k $478k 157% Dec 2025
 View chart
Geode Capital Management 354k $400k 0% Dec 2025
 View chart
Jane Street 207k $233k 14% Dec 2025
 View chart
Susquehanna International 184k $208k -2% Dec 2025
 View chart
Citadel Advisors 170k $193k 196% Dec 2025
 View chart
Northern Trust 149k $169k 57% Dec 2025
 View chart
State Street Corporation 124k $140k 11% Dec 2025
 View chart
Seven Fleet Capital Management 118k $133k 100% Dec 2025
 View chart
Bank of Nova Scotia 106k $120k 0% Dec 2025
 View chart
GSA Capital Partners 93k $105k 5% Dec 2025
 View chart
Ieq Capital 92k $104k 0% Dec 2025
 View chart
Bridgeway Capital Management 76k $86k 111% Dec 2025
 View chart
Nan Fung Trinity 42k $47k 0% Dec 2025
 View chart
DekaBank Deutsche Girozentrale 41k $508k 0% Dec 2025
 View chart
Callan Family Office 28k $32k 43% Dec 2025
 View chart
Marshall Wace 26k $30k -33% Dec 2025
 View chart
HC Advisors 24k $27k 9% Dec 2025
 View chart
Point72 Asset Management 20k $23k 100% Dec 2025
 View chart
JSF Financial 18k $20k 0% Dec 2025
 View chart
Goldman Sachs Group 17k $20k -7% Dec 2025
 View chart
Nine Masts Capital 16k $18k 100% Dec 2025
 View chart
Moneta Group Investment Advisors 15k $17k 0% Dec 2025
 View chart
Commonwealth Equity Services 15k $17k -27% Dec 2025
 View chart
Virtu Financial 14k $15k 100% Dec 2025
 View chart
Lido Advisors 13k $24k 0% Dec 2025
 View chart
FMR 13k $15k 0% Dec 2025
 View chart
Abel Hall 13k $14k 0% Dec 2025
 View chart
Barclays 11k $12k 0% Dec 2025
 View chart
Hsbc Holdings 10k $12k -7% Dec 2025
 View chart
Simplex Trading 3.6k $4.0k 100% Dec 2025
 View chart
Tower Research Capital 3.1k $3.6k -18% Dec 2025
 View chart
NISA Investment Advisors 1.1k $1.3k 0% Dec 2025
 View chart
Bradley & Co. Private Wealth Management 1.0k $1.1k 0% Dec 2025
 View chart
Group One Trading 518.00 $584.977400 100% Dec 2025
 View chart
Bnp Paribas Arbitrage, Snc 480.00 $542.016000 0% Dec 2025
 View chart
SBI Securities 412.00 $466.013200 -2% Dec 2025
 View chart
Pnc Financial Services 100.00 $113.000000 0% Dec 2025
 View chart
CWM 96.00 $0 -33% Dec 2025
 View chart
Optiver Holding B.V. 27.00 $30.998700 -4% Dec 2025
 View chart

Who sold out of Alx Oncology Hldgs?

Fund or Company Name Date Sold Shares Held Valued At
Ameriprise Financial Sep 2025 653k $1.2M
Privium Fund Management B.V. Sep 2025 509k $932k
Wealth Enhancement Advisory Services Dec 2025 38k $41k
XTX Topco Sep 2025 27k $49k
Hrt Financial Sep 2025 23k $41k
Qube Research & Technologies Sep 2025 17k $31k
AQR Capital Management Sep 2025 11k $20k
Federated Investors Sep 2025 2.4k $4.3k
EverSource Wealth Advisors Sep 2025 499.00 $914.816700